Positive and negative psychotropic effects of levetiracetam

被引:71
作者
Heimstaedter, C. [1 ]
Fritz, N. E. [1 ]
Kockelmann, E. [1 ]
Kosanetzky, N. [1 ]
Eiger, C. E. [1 ]
机构
[1] Univ Hosp Bonn, Dept Epileptol, D-53105 Bonn, Germany
关键词
levetiracetam; behavior; efficacy; aggression; activation;
D O I
10.1016/j.yebeh.2008.05.012
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objectives: The goals of this study were to observe behavioral changes in patients receiving levetiracetam (LEV), a newer antiepileptic drug (AED), and to answer the question of whether LEV exerts a specific effect on impulse control and aggression. Methods: We asked 288 consecutive patients with epilepsy on LEV (90% polytherapy, mean dose = 2689 mg) and 135 relatives whether LEV caused a positive or negative behavioral change. Forty-three patients on other AEDs served as a control group. Ratings were related to patient characteristics, efficacy, dose, drug load, bidirectional ratings of change in behavioral domains, and questionnaires on personality (Fragebogens zur Personlichkeit bei zerebralen Erkrankungen) and impulsivity (Barratt Impulsiveness Scale-11). Results: LEV was Fated as very effective by 40% of the patients. In Contrast to only 9% of the controls, a considerable number of patients reported a behavioral change while taking LEV (12% very negative, 25% negative, 16% positive, 6% very positive). Negative ratings were due to loss of self-control, restlessness, sleep problems, and, most importantly, aggression. Positive ratings were due to increased energy, vigilance, and activation. increases in psychomotor speed, concentration, and remote memory indicated subjectively experienced positive effects on cognition. The proxy reports indicated reliable self-reports. Reported change was not related to type of epilepsy, co-therapy, dose, drug load, or psychiatric history. Negative effects were, however, associated with poorer seizure control, mental retardation, indicators of an organic psychosyndrome, and nonplanning impulsiveness. Conclusion:The results indicate that LEV exerts a dose-independent stimulating effect that can be positive or negative. Aggression is a prominent feature. Lack of efficacy, mental retardation, and presumably also pre-intake disposition (organic psychosyndrome, impulsivity) may be helpful in predicting whether additional activation under LEV will be positive or negative. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 32 条
[1]   Benefit-risk assessment of levetiracetam in the treatment of partial seizures [J].
Abou-Khalil, B .
DRUG SAFETY, 2005, 28 (10) :871-890
[2]  
[Anonymous], 2004, REV CONTEMP PHARMACO
[3]   Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study [J].
Beran, RG ;
Berkovic, SF ;
Black, AB ;
Danta, G ;
Hiersemenzel, R ;
Schapel, GJ ;
Vajda, FJE .
EPILEPSY RESEARCH, 2005, 63 (01) :1-9
[4]   Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine [J].
Beran, RG ;
Gibson, RJ .
EPILEPSIA, 1998, 39 (03) :280-282
[5]   Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs [J].
Bergey, GK .
EPILEPSIA, 2005, 46 :161-168
[6]   Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy [J].
Berkovic, S. F. ;
Knowlton, R. C. ;
Leroy, R. F. ;
Schiemann, J. ;
Falter, U. .
NEUROLOGY, 2007, 69 (18) :1751-1760
[7]   Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison [J].
Bootsma, H. P. R. ;
Ricker, L. ;
Diepman, L. ;
Gehring, J. ;
Hulsman, J. ;
Lambrechts, D. ;
Leenen, L. ;
Majoie, M. ;
Schellekens, A. ;
de Krom, M. ;
Aldenkamp, A. P. .
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2008, 17 (01) :19-26
[8]   Tolerability of levetiracetam in elderly patients with CNS disorders [J].
Cramer, JA ;
Leppik, IE ;
De Rue, K ;
Edrich, P ;
Krämer, G .
EPILEPSY RESEARCH, 2003, 56 (2-3) :135-145
[9]   Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam [J].
Cramer, JA ;
Van Hammée, G .
EPILEPSY & BEHAVIOR, 2003, 4 (02) :118-123
[10]   Effect of levetiracetam on epilepsy-related quality of life [J].
Cramer, JA ;
Arrigo, C ;
Van Hammée, G ;
Gauer, LJ ;
Cereghino, JJ .
EPILEPSIA, 2000, 41 (07) :868-874